Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Bully88on Dec 16, 2020 8:01am
138 Views
Post# 32116851

RE:Chris Thompson Research calls for revenue breakout in 2021

RE:Chris Thompson Research calls for revenue breakout in 2021I have been waiting for what seems like forever for this company to make it into the market and the time has officially come.

I am beyond excited for this cpmpanys future growth.

this quote from Chris Thompsons report is the clearest sign that things have turned around and going to be successfull

For every 500 units deployed by MedX, the Company books $1 million in hardware sales and forecasts $1.5 to $2.0 million of annual SaaS revenue. With the Brazilian and other recent orders, revenue could land in the $5.6 million to $8.4 million range in 2021, more than 10 times what was reported in 2019.


Are there still risks of diluting for more capital? yes

but the rewards far outweigh the risk at this point and worth a buy IMO


Cheers and goodluck to all

<< Previous
Bullboard Posts
Next >>